Literature DB >> 23791424

Risk factors for recurrent epistaxis: importance of initial treatment.

Yuji Ando1, Jiro Iimura2, Satoshi Arai2, Chiaki Arai2, Manabu Komori2, Matsusato Tsuyumu2, Takanori Hama3, Yasushi Shigeta2, Atsushi Hatano2, Hiroshi Moriyama3.   

Abstract

OBJECTIVE: A retrospective study of risk factors for recurrent epistaxis and initial treatment for refractory posterior bleeding was performed. Based on the results, proposals for appropriate initial treatment for epistaxis by otolaryngologists are presented.
METHODS: The data of 299 patients with idiopathic epistaxis treated during 2008-2009 were analyzed by multivariate logistic regression analysis. Treatment data for 101 cases of posterior bleeding were analyzed using the chi-square test.
RESULTS: Recurrent epistaxis occurred in 32 cases (10.7%). Unidentified bleeding point (adjusted odds ratio (OR) 5.67, 95% confidence interval (CI) 1.83-17.55, p=0.003) was predictive of an increased risk of recurrent epistaxis, and electrocautery (adjusted odds ratio (OR) 0.07, 95% confidence interval (CI) 0.03-0.17, p=0.000) was predictive of a decreased risk of recurrent epistaxis. In terms of initial treatment for posterior bleeding, the rate of recurrent epistaxis was significantly lower for patients who underwent electrocautery as initial treatment compared with those who did not (6.4% vs. 40.7%, p<0.01), and it was significantly higher for those who underwent endoscopic gauze packing compared with those who did not (39.5% vs. 15.9%, p<0.01).
CONCLUSION: In the present study, the risk factors for recurrent epistaxis were unidentified bleeding point. Thus, it is important to identify and cauterize a bleeding point to prevent recurrent epistaxis. The present results also suggest the effectiveness of electrocautery and the higher rate of recurrent epistaxis for patients who underwent gauze packing as initial treatment for posterior bleeding. Electrocautery should be the first-choice treatment of otolaryngologists for all bleeding points of epistaxis, and painful gauze packing may be inadvisable for posterior bleeding. More cases of posterior bleeding are needed for future studies involving multivariate analyses and appropriate analyses of factors related to hospitalization, surgery, and embolization.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endoscopic electrocautery; Gauze packing; Recurrent epistaxis; Risk factor; Unidentified bleeding point

Mesh:

Year:  2013        PMID: 23791424     DOI: 10.1016/j.anl.2013.05.004

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  Factors influencing recurrent emergency department visits for epistaxis in the elderly.

Authors:  Mohamad R Chaaban; Dong Zhang; Vicente Resto; James S Goodwin
Journal:  Auris Nasus Larynx       Date:  2017-12-06       Impact factor: 1.863

2.  The long-term fate of epistaxis patients with exposure to antithrombotic medication.

Authors:  Rafael R Stadler; Rahel Kindler; David Holzmann; Michael B Soyka
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-09       Impact factor: 2.503

3.  Superselective microcoil embolization in severe intractable epistaxis: an analysis of 12 consecutive cases from an otorhinolaryngologic and an interventional neuroradiologic point of view.

Authors:  D U Seidel; S Remmert; F Brassel; M Schlunz-Hendann; D Meila
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-11       Impact factor: 2.503

4.  Association of Hypertension With the Risk and Severity of Epistaxis.

Authors:  Hayoung Byun; Jae Ho Chung; Seung Hwan Lee; Jiin Ryu; Changsun Kim; Jeong-Hun Shin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-09-10       Impact factor: 6.223

5.  Is There a Relationship Between Epitaxis and Anatomical Variations?

Authors:  Ismail Salcan; Abdulkerim Olgun
Journal:  Eurasian J Med       Date:  2019-07-29

6.  Epistaxis and Its Associated Factors Among Precollege Students in Southern Ethiopia.

Authors:  Gemechu Ameya; Gelila Biresaw; Hayat Mohammed; Abebayehu Chebud; Melese Meskele; Mohammed Hussein; Muktar Endris
Journal:  J Blood Med       Date:  2021-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.